Breaking News

 
31 December 2009
Quality of life in chronic pruritus measured by the ITCHYQoL
 
30 December 2009
Patients with severe psoriasis with no history of cardiovascular risk are at increased risk of cardiovascular mortality
 
29 December 2009
A controlled trial of topical tacrolimus for the treatment of pruritus in atopic dermatitis patients
 
28 December 2009
Effect of nalfurafine in severe itch in hemodialysis patients: A phase III, randomized, double-blind, placebo-controlled study
 
24 December 2009
Pharmacology of nalfurafine: A novel kappa-opioid receptor agonist
 
23 December 2009
Serum levels of thymus and activation-regulated chemokine CCL17 in pediatric atopic dermatitis
 
22 December 2009
Guidelines for biologic interventions for psoriasis, 2009
 
21 December 2009
Psoriasis and risk of incident cancer: An observational study
 
18 December 2009
Inverse relation between contact allergy and psoriasis: Results from a patient- and population-based study
 
17 December 2009
Itch brain activity in atopic dermatitis: Association with disease intensity and severity
 
16 December 2009
Educational multidisciplinary training programs for patients with chronic psoriasis
 
15 December 2009
Predicting risk for infantile atopic dermatitis by genetic and environmental factors
 
14 December 2009
Circulating regulatory T cells upregulated by biological therapies and correlate with clinical response in psoriasis
 
11 December 2009
Measuring patient-relevant benefits in pruritus treatment: The development and validation of a specific outcomes tool
 
12 October 2009
Excessive body-weight and smoking increase the risk of onset of plaque-psoriasis
 
12 July 2009
A 12-week controlled evaluation of oral psoralen plus ultraviolet A for treatment of plaque-type psoriasis
 
12 January 2009
Once-weekly etanercept improves patient-reported outcomes in patients with mild-moderate psoriasis
 
 
1